Logo image of BH

BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

USA - NYSE:BH - US08986R3093 - Common Stock

360.86 USD
+4.7 (+1.32%)
Last: 10/17/2025, 6:40:00 PM
362.95 USD
+2.09 (+0.58%)
After Hours: 10/17/2025, 6:40:00 PM
Fundamental Rating

4

Taking everything into account, BH scores 4 out of 10 in our fundamental rating. BH was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. BH has an excellent financial health rating, but there are some minor concerns on its profitability. BH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BH was profitable.
In the past year BH had a positive cash flow from operations.
In multiple years BH reported negative net income over the last 5 years.
Each year in the past 5 years BH had a positive operating cash flow.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

BH has a Return On Assets of 4.57%. This is in the better half of the industry: BH outperforms 63.70% of its industry peers.
The Return On Equity of BH (6.70%) is better than 61.48% of its industry peers.
BH has a worse Return On Invested Capital (2.23%) than 68.15% of its industry peers.
BH had an Average Return On Invested Capital over the past 3 years of 4.28%. This is significantly below the industry average of 10.67%.
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROIC 2.23%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

BH's Profit Margin of 10.47% is fine compared to the rest of the industry. BH outperforms 78.52% of its industry peers.
BH's Operating Margin of 5.21% is on the low side compared to the rest of the industry. BH is outperformed by 61.48% of its industry peers.
BH's Operating Margin has improved in the last couple of years.
The Gross Margin of BH (38.13%) is worse than 65.93% of its industry peers.
In the last couple of years the Gross Margin of BH has grown nicely.
Industry RankSector Rank
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BH is destroying value.
Compared to 1 year ago, BH has about the same amount of shares outstanding.
Compared to 5 years ago, BH has less shares outstanding
BH has a worse debt/assets ratio than last year.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.40 indicates that BH is not in any danger for bankruptcy at the moment.
BH's Altman-Z score of 3.40 is fine compared to the rest of the industry. BH outperforms 77.04% of its industry peers.
BH has a debt to FCF ratio of 1.42. This is a very positive value and a sign of high solvency as it would only need 1.42 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.42, BH belongs to the best of the industry, outperforming 87.41% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that BH is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.14, BH is doing good in the industry, outperforming 79.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Altman-Z 3.4
ROIC/WACC0.27
WACC8.2%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BH has a Current Ratio of 1.38. This is a normal value and indicates that BH is financially healthy and should not expect problems in meeting its short term obligations.
BH has a Current ratio of 1.38. This is in the better half of the industry: BH outperforms 67.41% of its industry peers.
BH has a Quick Ratio of 1.35. This is a normal value and indicates that BH is financially healthy and should not expect problems in meeting its short term obligations.
BH's Quick ratio of 1.35 is fine compared to the rest of the industry. BH outperforms 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.35
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

BH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 310.05%, which is quite impressive.
Looking at the last year, BH shows a small growth in Revenue. The Revenue has grown by 4.14% in the last year.
BH shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.55% yearly.
EPS 1Y (TTM)310.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.18%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.62, the valuation of BH can be described as very cheap.
99.26% of the companies in the same industry are more expensive than BH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.40. BH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.62
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BH is valued a bit cheaper than 60.74% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BH indicates a rather cheap valuation: BH is cheaper than 85.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.27
EV/EBITDA 10.47
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BH!.
Industry RankSector Rank
Dividend Yield N/A

BIGLARI HOLDINGS INC-B

NYSE:BH (10/17/2025, 6:40:00 PM)

After market: 362.95 +2.09 (+0.58%)

360.86

+4.7 (+1.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-06 2025-11-06
Inst Owners88.79%
Inst Owner Change0%
Ins Owners0.4%
Ins Owner Change0%
Market Cap822.76M
Analysts43.33
Price TargetN/A
Short Float %30.89%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.62
Fwd PE N/A
P/S 2.18
P/FCF 13.27
P/OCF 9.5
P/B 1.4
P/tB 1.6
EV/EBITDA 10.47
EPS(TTM)137.55
EY38.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)27.19
FCFY7.54%
OCF(TTM)37.98
OCFY10.53%
SpS165.43
BVpS258.46
TBVpS225.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROCE 2.67%
ROIC 2.23%
ROICexc 2.72%
ROICexgc 3.1%
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
FCFM 16.44%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexcg growth 3Y-14.08%
ROICexcg growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Debt/EBITDA 1.34
Cap/Depr 59.46%
Cap/Sales 6.52%
Interest Coverage 250
Cash Conversion 141.88%
Profit Quality 156.94%
Current Ratio 1.38
Quick Ratio 1.35
Altman-Z 3.4
F-Score5
WACC8.2%
ROIC/WACC0.27
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)310.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.96%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.73%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y-30.77%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%